المؤلفون: Beigi YZ; Laboratory of System Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran., Lanjanian H; Software Engineering Department, Engineering Faculty, Istanbul Topkapi University, Istanbul, Turkey., Fayazi R; Laboratory of System Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran., Salimi M; Department of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran., Hoseyni BHM; Laboratory of System Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran., Noroozizadeh MH; Negah Eye Hospital, Tehran, Iran., Masoudi-Nejad A; Laboratory of System Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. amasoudin@ut.ac.ir.

المصدر: Molecular biomedicine [Mol Biomed] 2024 May 10; Vol. 5 (1), pp. 17. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/genetics , Melanoma*/pathology , Melanoma*/therapy , Melanoma*/drug therapy , Molecular Targeted Therapy*/methods , Genetic Heterogeneity* , Uveal Neoplasms*/genetics , Uveal Neoplasms*/therapy , Uveal Neoplasms*/pathology, Humans ; Neoplastic Cells, Circulating/metabolism ; Neoplastic Cells, Circulating/pathology ; Biomarkers, Tumor/genetics ; Mutation ; Circulating Tumor DNA/genetics ; Circulating Tumor DNA/blood ; Liquid Biopsy/methods